Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04635306 · ClinicalTrials.gov registry record · NA
13C-Spirulina Nitrogen Content GEBT Study
A NA study, sponsored by Cairn Diagnostics.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT04635306: Clinical Trial NA study, sponsored by Cairn Diagnostics.
NCT04635306 is a NA study that was terminated before completion, run by Cairn Diagnostics. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04635306, a NA study, was terminated before completion, sponsored by Cairn Diagnostics.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a difference in the human in vivo response to 13C-Spirulina meals manufactured using 13C-Spirulina containing different levels of protein (as measured by %nitrogen).
Primary Outcome
Determining the difference between measure gastric emptying rate (kPCD) results produced from the low %N 13C-Spirulina GEBT test meal and the FDA-approved test meal
Interventions
- DIAGNOSTIC_TEST Approved GEBT test meal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-10-21 |
| Est. Completion | 2021-06-25 |
| Phase | NA |
Why NCT04635306 stopped before completion
NCT04635306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Approved GEBT test meal is the first listed.
NCT04635306 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04635306 about?
NCT04635306 is a clinical study titled "13C-Spirulina Nitrogen Content GEBT Study". The purpose of this study is to determine whether there is a difference in the human in vivo response to 13C-Spirulina meals manufactured using 13C-Spirulina containing different levels of protein (as measured by %nitrogen).
What is the current status of trial NCT04635306?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2020-10-21. Estimated completion is 2021-06-25.
What interventions are being tested in trial NCT04635306?
The interventions under investigation include: Approved GEBT test meal (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04635306?
This trial is sponsored by Cairn Diagnostics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04635306's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI